ALIVUS LIFE SCIENCES
Back to Income Statement
|
ALIVUS LIFE SCIENCES Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,387 Cr | ₹2,283 Cr | ₹2,161 Cr | ₹2,123 Cr | ₹1,885 Cr |
What is the latest Revenue of ALIVUS LIFE SCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,387 Cr |
| Mar2024 | ₹2,283 Cr |
| Mar2023 | ₹2,161 Cr |
| Mar2022 | ₹2,123 Cr |
| Mar2021 | ₹1,885 Cr |
How is Revenue of ALIVUS LIFE SCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,387 Cr | 4.54 | |
| Mar2024 | ₹2,283 Cr | 5.64 | |
| Mar2023 | ₹2,161 Cr | 1.79 | |
| Mar2022 | ₹2,123 Cr | 12.63 | |
| Mar2021 | ₹1,885 Cr | - | |
Compare Revenue of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹14,195.8 Cr | 3.3% | 11.7% | 16.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 3.3% |
11.7% |
16.5% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses